Literature DB >> 24528073

Roles of MiR-101 and its target gene Cox-2 in early diagnosis of cervical cancer in Uygur women.

Chen Lin1, Fei Huang, Ya-Jing Zhang, Talafu Tuokan, Gulinaer Kuerban.   

Abstract

AIMS: Early diagnosis is important for cervical cancer treatment. This study aimed to characteriz the microRNA profile and target gene protein levels of cervical cancers in Uygur women for application in early diagnosis.
METHODS: The profiles of miRNA in cervical cancer and chronic cervicitis were analyzed with miRNAmicroarray V4.0. The expression of miR-101 was detected by real-time PCR and locked nucleotide acid in situ hybridization (LNA-ISH). Cox-2 protein levels were assessed by immunohistochemistry.
RESULTS: The microarray identified a set of 12 miRNAs significantly decreased in cervical cancer in comparison to the control group. Quantitative RT-PCR analysis showed miR-101 to be significantly downregulated in cancer tissues (p<0.05) while LNA-ISH showed miR-101 positive rates of 80% (20/25) and 8% (5/25) (p<0.05) in the control and cervical cancer groups. Cox-2 positive rates of cervical cancer and control groups were 84% (21/25) and 8% (2/25) (p<0.05).
CONCLUSIONS: Use of down-regulation of miR-101 and up-regulation of Cox-2 as markers may play a role in early diagnosis of cervical cancer in Uygur women.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24528073     DOI: 10.7314/apjcp.2014.15.1.45

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.

Authors:  Chen Lin; Fei Huang; Qiao-Zhi Li; Ya-Jing Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  Circulating MicroRNAs in Relation to Esophageal Adenocarcinoma Diagnosis and Survival.

Authors:  Jessica L Petrick; Ruth M Pfeiffer; Linda M Liao; Christian C Abnet; Xiaolin Wu; Marilie D Gammon; Thomas L Vaughan; Michael B Cook
Journal:  Dig Dis Sci       Date:  2021-01-06       Impact factor: 3.199

3.  Meta-analysis of microRNA expression profiling studies in human cervical cancer.

Authors:  Mei-Yi Li; Xiao-Xia Hu
Journal:  Med Oncol       Date:  2015-04-24       Impact factor: 3.064

4.  MicroRNA-101 regulates the viability and invasion of cervical cancer cells.

Authors:  Chen Lin; Fei Huang; Guqun Shen; Adilijiang Yiming
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.

Authors:  Xiangguang Shi; Lei Zhan; Can Xiao; Zhe Lei; Haiping Yang; Longqiang Wang; Jun Zhao; Hong-Tao Zhang
Journal:  Oncotarget       Date:  2015-08-07

Review 6.  Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.

Authors:  Michela Lucia Sammarco; Manuela Tamburro; Alessandra Pulliero; Alberto Izzotti; Giancarlo Ripabelli
Journal:  Microrna       Date:  2020

7.  Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.

Authors:  Anja Honegger; Daniela Schilling; Sandra Bastian; Jasmin Sponagel; Vladimir Kuryshev; Holger Sültmann; Martin Scheffner; Karin Hoppe-Seyler; Felix Hoppe-Seyler
Journal:  PLoS Pathog       Date:  2015-03-11       Impact factor: 6.823

8.  Micro ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion of lung cancer by regulating cyclooxygenase-2.

Authors:  Peng Lv; Peng Zhang; Xin Li; Yuan Chen
Journal:  Thorac Cancer       Date:  2015-06-23       Impact factor: 3.500

9.  Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.

Authors:  Ying Shao; Peng Li; Sheng-tao Zhu; Ji-ping Yue; Xiao-jun Ji; Zhen He; Dan Ma; Li Wang; Yong-jun Wang; Ye Zong; Yong-dong Wu; Shu-tian Zhang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.

Authors:  Dedong He; Zhongyi Yue; Guangjun Li; Liping Chen; Hailong Feng; Jianwei Sun
Journal:  Med Sci Monit       Date:  2018-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.